Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Journal of Viral Hepatitis|October 13, 2020
Hepatitis B surface antibody titres and hepatitis B reactivation with direct-acting antiviral therapy for hepatitis CShiva Poola, Sirish Sanaka, Kerry Sewell, et al.
Seminars in Liver Disease|February 26, 2005
Merging models of hepatitis C virus pathogenesisHans L Tillmann, Michael P Manns, K Lenhard Rudolph
Tropical Medicine & International Health : TM & IH|October 22, 2009
Hepatitis B treatment in resource poor settings: time for actionMark Thursz, Graham S Cooke, Andrew J Hall
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2013
Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for actionMaud Lemoine, Mark Thursz, Ramou Njie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2022
Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti-Tumor Necrosis Factor TherapyShiva Poola, Marykate Kratzer, Sirish Sanaka, et al.
Current Hepatology Reports|February 16, 2019
Novel Approaches to Causality Adjudication in Drug-Induced Liver DiseaseHans L Tillmann, Huiman X Barnhart, Jose Serrano, et al.
Alimentary Pharmacology & Therapeutics|December 14, 2025
Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab TreatmentShiva Poola, MaryKate Kratzer, Kerry Sewell, et al.
Medical Acupuncture|November 1, 2018
Can Battlefield Acupuncture Improve Colonoscopy Experience?Mohamed M Abdelfatah, Michelle C Beacham, Michael Freedman, et al.
Journal of Public Health Policy|August 17, 2012
In the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa: global health issues and funding agency responsibilitiesMaud Lemoine, Pierre-Marie Girard, Mark Thursz, et al.
Plos One|September 29, 2022
A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)Hans L Tillmann, Ayako Suzuki, Michael Merz, et al.
Pageof 21